A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
| Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
| O1 | O1 Baumwollfaser | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| O203 | O203 Tetramin | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| O214 | O214 CCD (Carbohyd.Determ.) | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| O215 | O215 Alpha-1,3-Gal | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| O70 | O70 Sperma/Ejakulat | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
| DESVENLA | O-Desmethyl-Venlafaxin | ng/ml | - | MATERIAL: Serum, METHODE: LC-MS | ||
| OESTRA | Oestradiol (E2) | ng/l | - | MATERIAL: Serum/Vollblut, METHODE: LIA | ||
| OESTRABV | Oestradiol bioverfügbar | pg/ml | - | MATERIAL: Serum/Vollblut, METHODE: | ||
| OESTRI | Oestriol (E3) | ug/l | - | MATERIAL: Serum/Vollblut, METHODE: FPIA | ||
| OESTRON | Oestron (E1) | pg/ml | 0.00 | - | 320.00 | MATERIAL: Serum/Vollblut, METHODE: RIA |
| OLAN | Olanzapin | µg/l | 20.000 | - | 80.000 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
| OMEGAFSR | Omega 3/6 Fettsren. + Quotient | - | MATERIAL: min. 4ml Serum | |||
| OMEGAFSREM | Omega 3/6 Fettsren.i.Erymembran | - | MATERIAL: min. 4ml EDTA | |||
| OMEGAFSRV | Omega 3/6 Fettsren. im Vollblut | - | MATERIAL: min. 4ml EDTA | |||
| OMEGAQ | Omega 3/6 Quotient EPA/AA | % | > | 15.00 | MATERIAL: Serum/Vollblut, METHODE: GC/MS | |
| OPIS | Opiate (S) | ug/l | < | 10.000 | MATERIAL: Serum/Vollblut; METHODE: FPIA | |
| OPIH | Opiate (U) | ng/ml | 0.0 | - | 300.0 | MATERIAL: Spontanharn, METHODE: EMIT |
| OPIPRAMOL | Opipramol | ug/l | 50.0 | - | 500.0 | MATERIAL: Serum; METHODE: HPLC |
| BZBELMKP | Oraler Gluc.toleranztest MKP | - | MATERIAL: Fluorid-Blut | |||
| ORGSRNU | Organische Säuren i.H. | - | Material: Spontanharn 5ml | |||
| OCRESOL | Ortho-Cresol | mg/l | 0.00 | - | 0.80 | MATERIAL: Spontanharn, METHODE: HPLC |
| OSMO-U | Osmolalität i.H. | mosmol/kg | 50.0 | - | 1200.0 | MATERIAL: Spontanharn |
| OSMOST | Osmolalität i.St. | mosm/kg | 280.0 | - | 390.0 | MATERIAL: Stuhl |
| OSMO | Osmolalität im Serum | mosmol/kg | 280.0 | - | 295.0 | MATERIAL: Serum/Vollblut |
| OSTEO | Osteocalcin | ng/ml | 4.60 | - | 65.40 | MATERIAL: Serum/Vollblut, METHODE: LIA |
| OSTEOPROT | Osteoprotegerin | pmol/l | 0.860 | - | 2.840 | MATERIAL: Serum/Vollblut, METHODE: |
| OVARAK | Ovar Antikörper | - | MATERIAL: Serum/Vollblut, METHODE: IFT | |||
| OXALAU | Oxalsäure i.24h H. | mg/l | - | MATERIAL: 24h-Sammelharn angesäuert, METHODE: | ||
| OXALAH | Oxalsäure i.24h H. | mg/24h | 0.00 | - | 43.90 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: |
| OXAZEPAM | Oxazepam | ug/l | 200.00 | - | 1500.00 | MATERIAL: Serum, METHODE: LC-MS |
| OXCARBA | Oxcarbazepin (10-OH-Metab.) | ug/ml | 10.00 | - | 30.00 | MATERIAL: Vollblut/Serum |
| OXYCODON | Oxycodon | ug/l | 5.000 | - | 50.000 | MATERIAL: Serum, Methode: LC-MS |